A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma
Top Cited Papers
Open Access
- 27 August 2002
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 87 (5), 491-496
- https://doi.org/10.1038/sj.bjc.6600505
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group BLung Cancer, 2001
- Phase II Study of Vinorelbine in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2000
- The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancerLung Cancer, 2000
- Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesotheliomaEuropean Journal Of Cancer, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- A phase II study of gemcitabine in patients with malignant pleural mesotheliomaCancer, 1999
- A Proposed New International TNM Staging System for Malignant Pleural MesotheliomaChest, 1995
- Continuing increase in mesothelioma mortality in BritainThe Lancet, 1995
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group StudyInvestigational New Drugs, 1988